1-15777183-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017556.4(FBLIM1):c.904G>A(p.Val302Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000535 in 1,606,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017556.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBLIM1 | NM_017556.4 | c.904G>A | p.Val302Ile | missense_variant | 8/9 | ENST00000375766.8 | NP_060026.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBLIM1 | ENST00000375766.8 | c.904G>A | p.Val302Ile | missense_variant | 8/9 | 2 | NM_017556.4 | ENSP00000364921 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152130Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000599 AC: 15AN: 250528Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135424
GnomAD4 exome AF: 0.0000454 AC: 66AN: 1454192Hom.: 0 Cov.: 30 AF XY: 0.0000360 AC XY: 26AN XY: 721774
GnomAD4 genome AF: 0.000131 AC: 20AN: 152248Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74428
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.904G>A (p.V302I) alteration is located in exon 8 (coding exon 6) of the FBLIM1 gene. This alteration results from a G to A substitution at nucleotide position 904, causing the valine (V) at amino acid position 302 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at